Home
Silverarc Capital Management reported a 2.83% stake in Avalo Therapeutics AVTX · 524,436 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 2.83%
- Last report
- 5.48% · filed 25/11/14
- Shares held
- 524,436 sh
- Class
- Class A Common Stock
- Event date
- 25/12/31
- Filed
- 26/02/10
2.83% stake · below 5%
- Stake
- 2.83%
- Last report
- 5.48%
- Since last report
- −2.6pp
Avalo Therapeutics trades, last 26 weeks
What else happened in Avalo Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Silverarc Capital Management's other 5% stake reports
- Silverarc Capital Management
5% stakeCellectar Biosciences
5% stakeCellectar Biosciences
CLRB
9.99% stake
851,285 sh
9.99% stake
Filed 08/14
- Silverarc Capital Management
5% stakeTela Bio
5% stakeTela Bio
TELA
4.8% stake
2,137,201 sh
4.8% stake
Filed 08/11
- Silverarc Capital Management
5% stakeElutia
5% stakeElutia
ELUT
4.9% stake
2,192,980 sh
4.9% stake
Filed 08/11
- Silverarc Capital Management
5% stakeNextCure
5% stakeNextCure
NXTC
4.9% stake
176,057 sh
4.9% stake
Filed 05/13
- Silverarc Capital Management
5% stakeHelix Acquisition Corp. III
5% stakeHelix Acquisition Corp. III
HLXC
6.8% stake
1,208,986 sh
6.8% stake
Filed 05/13
